Skip to main content
DeFi Millionaire book on Amazon (opens in a new tab)

DN Decision Briefs / Platform evidence

Veranta (formerly Avantis)

Veranta documents USDC margin on Base and session-based trading permissions. Its fee pages disagree on maker rates and Upside borrowing costs. Treat zero-commission claims as product-specific; no definitive total-cost comparison or live security assessment is established.

Reviewed 2026-10-22Version 1.1.0No live execution tests

What Matters

The name changed. Recheck the conditions.

Review of all six brief claims against nine current official sources retrieved through web search and page retrieval. Original overview and blog references are replaced by specific product pages. No live trading, wallet-signing, revocation, payout or eligibility test; the profit-sharing tier graphic was not verified.

Old Avantis instructions may describe a different product configuration. This brief records what current accessible provider sources establish and leaves unsupported details unknown.

DN Evidence Block

Claims, sources and practical consequences.

Review of all six brief claims against nine current official sources retrieved through web search and page retrieval. Original overview and blog references are replaced by specific product pages. No live trading, wallet-signing, revocation, payout or eligibility test; the profit-sharing tier graphic was not verified. Reviewed by Decentralised News editorial research. Review status: internal. Independent review claimed: No.

Provider-reported

Is this still Avantis?

The official developer organisation identifies Veranta as formerly Avantis and links to the Veranta website and documentation. This review does not date the rebrand or establish equivalence between old and current product instructions.

Why it matters: Use the current name and documentation; do not assume older instructions still describe the product.

Official developer organisation: formerly Avantis
Link to this dated claim
Inspect evidence trail
Evidence type
Provider documentation
Review scope
Nine official sources reviewed across the six Veranta claims. Documentation conflicts are explicit; no live execution, payout, permission or eligibility test.
Underlying review
2026-10-22 · brief v1.1.0
Recorded reviewer
Decentralised News editorial research. This does not identify an independent auditor.
Stable claim ID
dn:claim:veranta:identity
Review saved claims

Sources and their limits

1 linked document from one publisher origin (veranta). Multiple documents do not establish independent corroboration.

What would change this conclusion?

A changed official identity statement or product migration notice.

Panel published 2026-10-24. The underlying review date is unchanged. No new live test or named independent reviewer is implied.

Open annotation data v1.8.0
Provider-reported

Which network and margin asset are described?

The collateral page describes USDC margin and isolated positions. The terms identify Base as the protocol network. These are provider statements, not tests of deployed collateral or loss boundaries.

Why it matters: Confirm the selected network, token and deposit route before moving assets. This does not establish every supported funding method.

Collateral and position sizingTerms of Service, revised September 2026
Link to this dated claim
Inspect evidence trail
Evidence type
Provider documentation
Review scope
Nine official sources reviewed across the six Veranta claims. Documentation conflicts are explicit; no live execution, payout, permission or eligibility test.
Underlying review
2026-10-22 · brief v1.1.0
Recorded reviewer
Decentralised News editorial research. This does not identify an independent auditor.
Stable claim ID
dn:claim:veranta:collateral
Review saved claims

Sources and their limits

2 linked documents from one publisher origin (veranta). Multiple documents do not establish independent corroboration.

What would change this conclusion?

A changed collateral specification for the exact network and product mode.

Panel published 2026-10-24. The underlying review date is unchanged. No new live test or named independent reviewer is implied.

Open annotation data v1.8.0
Documentation conflict

Does zero commission mean zero total cost?

The fee schedule prose assigns 4.5 bps to takers and 1 bp to makers; its table reverses the labels. The maker/taker page instead lists 0.001% (0.1 bp) for makers. The schedule includes borrowing for Upside, while Upside mechanics says no borrowing and describes trader-to-trader funding. RWA commission is described as zero during growth mode, with spread and holding costs. Profit-sharing text describes retaining 75–95%, depending on ROI; the tier graphic and live payout calculation were not verified.

Why it matters: Do not use these conflicting figures as a definitive fee quote. Check the exact product and order breakdown, including funding, spread and profit share. DN has not established a cheapest venue or a complete numerical schedule.

Fee schedule by asset classMaker and takerUpside mechanicsUpside profit sharing
Link to this dated claim
Inspect evidence trail
Evidence type
Documentation conflict
Review scope
Nine official sources reviewed across the six Veranta claims. Documentation conflicts are explicit; no live execution, payout, permission or eligibility test.
Underlying review
2026-10-22 · brief v1.1.0
Recorded reviewer
Decentralised News editorial research. This does not identify an independent auditor.
Stable claim ID
dn:claim:veranta:fees
Review saved claims

Sources and their limits

4 linked documents from one publisher origin (veranta). Multiple documents do not establish independent corroboration.

  • Fee schedule by asset classReviewed 2026-10-22. Source publication/update date: not recorded in this snapshot.
  • Maker and takerReviewed 2026-10-22. Source publication/update date: not recorded in this snapshot.
  • Upside mechanicsReviewed 2026-10-22. Source publication/update date: not recorded in this snapshot.
  • Upside profit sharingReviewed 2026-10-22. Source publication/update date: not recorded in this snapshot.

What would change this conclusion?

A consistent maker/taker and Upside fee schedule, followed by a matching product-mode quote. No numerical rate is selected from conflicting pages.

Panel published 2026-10-24. The underlying review date is unchanged. No new live test or named independent reviewer is implied.

Open annotation data v1.8.0
Not measured

Has DN verified execution quality?

The current page describes oracle-based pricing, spreads and RWA request-for-quote execution. It also retains unfilled confirmation placeholders for Korean-equity spread and price-check arrangements. Provider examples are not independent DN fill or latency measurements.

Why it matters: No measured fill-quality, latency, withdrawal or stop-loss ranking is supported here.

Execution and pricing
Link to this dated claim
Inspect evidence trail
Evidence type
Not independently measured
Review scope
Nine official sources reviewed across the six Veranta claims. Documentation conflicts are explicit; no live execution, payout, permission or eligibility test.
Underlying review
2026-10-22 · brief v1.1.0
Recorded reviewer
Decentralised News editorial research. This does not identify an independent auditor.
Stable claim ID
dn:claim:veranta:execution
Review saved claims

Sources and their limits

1 linked document from one publisher origin (veranta). Multiple documents do not establish independent corroboration.

What would change this conclusion?

Resolved provider placeholders and reproducible independent execution measurements, with market conditions and sample disclosed.

Panel published 2026-10-24. The underlying review date is unchanged. No new live test or named independent reviewer is implied.

Open annotation data v1.8.0
Provider-reported

What authority does one-click trading require?

The detailed page describes session signers with user-selected expiry and revocation. EVM-wallet gas sponsorship requires Smart Wallet mode; ordinary transactions without that mode pay gas. DN did not inspect live signing requests or test expiry and revocation.

Why it matters: Read the exact session authority and wallet mode before signing, and verify revocation independently. Documented controls do not establish deployed safety.

Gasless and one-click trading
Link to this dated claim
Inspect evidence trail
Evidence type
Provider documentation
Review scope
Nine official sources reviewed across the six Veranta claims. Documentation conflicts are explicit; no live execution, payout, permission or eligibility test.
Underlying review
2026-10-22 · brief v1.1.0
Recorded reviewer
Decentralised News editorial research. This does not identify an independent auditor.
Stable claim ID
dn:claim:veranta:permissions
Review saved claims

Sources and their limits

1 linked document from one publisher origin (veranta). Multiple documents do not establish independent corroboration.

What would change this conclusion?

A review of current signing requests, expiry and revocation behaviour. Documentation alone is not a deployed-permission audit.

Panel published 2026-10-24. The underlying review date is unchanged. No new live test or named independent reviewer is implied.

Open annotation data v1.8.0
Provider-reported

Does wallet access establish eligibility?

The reviewed terms exclude defined U.S. persons and restricted persons and require users to meet age and other conditions.

Why it matters: Read the complete current terms. Absence from these examples is not confirmation of eligibility or local legal compliance.

Terms of Service, revised September 2026
Link to this dated claim
Inspect evidence trail
Evidence type
Provider documentation
Review scope
Nine official sources reviewed across the six Veranta claims. Documentation conflicts are explicit; no live execution, payout, permission or eligibility test.
Underlying review
2026-10-22 · brief v1.1.0
Recorded reviewer
Decentralised News editorial research. This does not identify an independent auditor.
Stable claim ID
dn:claim:veranta:access
Review saved claims

Sources and their limits

1 linked document from one publisher origin (veranta). Multiple documents do not establish independent corroboration.

What would change this conclusion?

Revised terms or relevant individual circumstances; no eligibility conclusion is made here.

Panel published 2026-10-24. The underlying review date is unchanged. No new live test or named independent reviewer is implied.

Open annotation data v1.8.0

Evidence boundary

No invented rates. No implied guarantees.

  • Definitive maker/taker rate mapping and current pair-specific costs
  • Consistent Upside borrowing treatment and verified profit-sharing tier calculation
  • Live permission scope, expiry enforcement and revocation behaviour
  • Korean-equity execution details left as confirmation placeholders by the provider
  • Live execution, stop-loss and withdrawal performance
  • Individual legal access and suitability

Detail pages unavailable during this review

    The overview, provider product explanation and terms were accessible. Missing details are not filled with historical rates or third-party assumptions.

    No numerical all-in cost is calculated. A valid comparison needs contemporaneous quotes for matching assets, product modes, notional sizes, directions and holding periods, with entry, holding and exit costs included.

    Your research record

    Keep the evidence.
    Keep its limits.

    The receipt preserves the provider sources and research gaps at version 1.1.0.

    It is not a recommendation, approval, live quote or alert subscription. No account, balance, wallet or country is requested.

    Scope
    Base
    Collateral scope
    USDC
    Evidence version
    1.1.0 / 2026-10-22
    Live tested
    No

    Open evidence JSON

    Change record

    Reviewed dates, not inferred launch dates.

    1. DN evidence revision

      Re-reviewed all six claims with nine official sources. Incorporated the previously accessed detail pages, recorded the additional maker-rate unit discrepancy and execution-page placeholders, and retained live-test limitations. Historical 1.0.0 and its 15 October follow-up remain unchanged.

    2. DN publication

      Initial Veranta brief with Avantis alias. Verified the identity using provider sources; recorded detail-page access gaps. This is the DN review date, not the rebrand announcement date.

    Review triggers: A reconciled fee schedule or corrected execution documentation; Changed collateral, session-permission or access terms; A substantiated correction; The 14-day review deadline. No automated provider surveillance runs for this brief.

    How to use this research

    Provider-reported describes the source of a statement, not an independent endorsement. Unknown and not measured identify evidence gaps. A documentation review does not confer an operational-status classification or establish user eligibility.

    DN has an existing Avantis referral entry. Its applicability after the rebrand has not been verified in this brief. No new referral destination or active partner CTA is supplied. Compensation has no role in the evidence labels.

    Educational research only, not investment, legal or tax advice. Leveraged derivatives can cause substantial losses.

    Report a correction